Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Healthcare
/
Stratec
SBS
Stratec
Aging Populations And Automation Will Spur Diagnostic Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
12 Jul 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
€50.00
48.3% undervalued
intrinsic discount
20 Aug
€25.85
Loading
1Y
-41.6%
7D
1.2%
Author's Valuation
€50.0
48.3% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
€50.0
48.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
339m
2014
2017
2020
2023
2025
2026
2028
Revenue €338.8m
Earnings €41.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.88%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.14%
Calculation
€41.36m
Earnings '28
x
17.33x
PE Ratio '28
=
€716.81m
Market Cap '28
€716.81m
Market Cap '28
/
12.16m
No. shares '28
=
€58.97
Share Price '28
€58.97
Share Price '28
Discounted to 2025 @ 6.11% p.a.
=
€49.36
Fair Value '25